BioGenerator is the investment arm of BioSTL.

BioGenerator produces a sustained pipeline of successful bioscience companies and entrepreneurs in St. Louis by creating, growing and investing in biotech startups.

BioGenerator is a nonprofit subsidiary of BioSTL, which advances St. Louis’ prosperity by cultivating a thriving bioscience sector, building regional capacity to capitalize on St. Louis’ world-class medical and plant biosciences.

For more information, visit BioGenerator or follow their updates on:



  • 24

BioGenerator Articles

Shared Services in the St. Louis AgTech and BioTech Innovation Districts

Big Pharma Teams Up with St. Louis Immunotherapy Startup & Why it Matters

St. Louis Manufacturing: Tradition and New Direction

STL AgTech Ecosystem Partners to Offer 5 Arch Grants to AgriFoodTech Startups

St. Louis Startup Scene: Balto Opens Office, Brain-Computer Interface Cleared to Sell

Insect Control AgTech Startup Raises $1M

Canopy Biosciences Acquired by Bruker After 4 Years As BioGenerator Incubated Startup

In 2019, BioGenerator Invested $3.2 Million in 16 Bioscience Companies in St. Louis

BioGenerator’s New Strategies Address St. Louis’ Talent Shortage

NYC Company Healthy Bytes Raises $1.25M to Relocate to St. Louis

Phas3 Wins Paid Pilot at Colorado Hospitals

Readout Health Produces New Medical Device to Easily Track Nutritional Ketosis

BioGenerator Wins $750,000 in Federal Funds to Expand Labs and Grants to Build New St. Louis AgTech Companies

Cortex Expands with Re-invention of Historic 4340 Duncan Building

VaxNewMo’s Vaccine Breakthrough Published in Nature

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

A “No” from Arch Grants Isn’t a “No” to Your Business

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Round in Canopy BioSciences


Local Immunotherapy Startup Attracts $3 Million Investment

SentiAR Scored A Major Milestone In Federal Grant Peer Review Process


SentiAR Awarded $2.2 Million Federal Grant to Advance Augmented Reality Device for Cardiologists

St Louis Startup Boom Was 20 Years In The Making


BioGenerator Wins $300K Federal Grant to Build Bioscience Companies In St. Louis


Biotech Crop Startup Plastomics Raises Investment For Early Seed Round

St Louis Bioscience Startup Acquired at $100 Million Valuation

The Agile Mission of BioGenerator’s Grants Program

BioSTL Fundamentals

How BioSTL Fundamentals is Elevating Early-Stage Entrepreneurs

Dollar sign fundraising

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

Dr. Juan Arhancet, Apse

Why BioGenerator Works


Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

St. Louis Startup Accelerator Guide

Cultivation Capital Leads $1.2M Financing Round in S4

Founder Series: Joseph Monahan of Confluence

BioGenerator Lab

Breaking Down BioGenerator

BioGenerator Company Accuronix Targets Pancreatic Cancer

STL Startup Funding

STL Startup Funding Guide

Bio STL Global STL EQ

International Affair

Disrupting Infection with Nanotechnology and Tom Cohen

St. Louis Cited As An Example of “The Right Way to Build a Tech City.”

Why All Wine Drinkers Will Love StiQit

Can St. Louis Become the Next Bioscience Hub?

From NY To STL: Why This Life-Science Company Relocated To The Midwest

BioGenerator Gets International Nod, Arch Angels Flying High, Appistry’s Samson vs Goliath Legal Battle

GirlsAskGuys Raises $1,000,000

Founder of Kypha Awarded 2013’s St. Louis Entrepreneur of the Year

Two St. Louis Venture Capital Firms Make Forbes ‘Big Money Midwest’ List